Non-competitive time-resolved immunofluorometric assays for determination of human insulin-like growth factor I and II.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Growth regulation

• Publication date

  1995-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 8745141
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Free insulin‐like growth factors (IGF‐I and IGF‐II) in human serum

  1994cited by this paper
• Decreased ternary complex formation and predominance of a 29 kDa IGFBP-3 fragment in human fetal serum.

  1994cited by this paper
• A novel method for the extraction of sheep insulin-like growth factors-I and -II from plasma prior to radioimmunoassay.

  1993cited by this paper
• Measurement of insulin-like growth factor-II in human plasma using a specific monoclonal antibody-based two-site immunoradiometric assay.

  1993cited by this paper
• Comparison of extraction methods for insulin-like growth factor-I in rat serum.

  1992cited by this paper
• Measurement of insulin-like growth factor-II in physiological fluids and tissues. I. An improved extraction procedure and radioimmunoassay for human and rat fluids.

  1991cited by this paper
• Radioimmunoassay for insulin-like growth factor-I: solutions to some potential problems and pitfalls.

  1991cited by this paper
• Comparison of acid ethanol extraction and acid gel filtration prior to IGF-I and IGF-II radioimmunoassays: improvement of determinations in acid ethanol extracts by the use of truncated IGF-I as radioligand.

  1991cited by this paper
• Enzyme-linked immunosorbent assay for human insulin-like growth factor-I using monoclonal and polyclonal antibodies with defined epitope recognition.

  1990cited by this paper
• Insulin-like growth factors I and II.

  1990cited by this paper
• Identification of a family of insulin-like growth factor II secreted by cultured rat epithelial-like cell line 18,54-SF: application of a monoclonal antibody.

  1989cited by this paper
• Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations.

  1989cited by this paper
• A specific radioimmunoassay for insulin-like growth factor II: the interference of IGF binding proteins can be blocked by excess IGF-I.

  1988cited by this paper
• Chemiluminescence immunoassay for somatomedin C in serum.

  1987cited by this paper
• Specific immunoradiometric assay of insulin-like growth factor I with use of monoclonal antibodies.

  1987cited by this paper
• Serum somatomedin binding proteins: physiologic significance and interference in radioligand assay.

  1987cited by this paper
• Monoclonal and polyclonal antibodies compared for radioimmunoassay of somatomedin-C in patients with acromegaly or hypopituitarism.

  1987cited by this paper
• Radioimmunoassay of somatomedin-C in filter paper discs containing dried blood.

  1987cited by this paper
• Immunoreactive IGF-II in serum of healthy subjects and patients with growth hormone disturbances and uraemia.

  1984cited by this paper
• Characterization of an insulin-like growth factor-I/somatomedin-C radioimmunoassay specific for the C-peptide region.

  1982cited by this paper
• A radioimmunoassay for insulin-like growth factor II specific for the C-peptide region.

  1982cited by this paper
• Monoclonal antibodies directed to human insulin‐like growth factor I (IGF I)

  1982cited by this paper
• Pitfalls in the somatomedin-C radioimmunoassay.

  1982cited by this paper
• Radioimmunoassay for somatomedin C: comparison with radioreceptor assay in patients with growth-hormone disorders, hypothyroidism, and renal failure.

  1982cited by this paper
• Radioimmunological determination of insulinlike growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia.

  1981cited by this paper
• Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: a comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum.

  1980cited by this paper
• Radioimmunoassay of a basic somatomedin: comparison of various assay techniques and somatomedin levels in various sera.

  1979cited by this paper
• Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay.

  1977cited by this paper

• Targeted proteomics of serum IGF-I, -II, IGFBP-2, -3, -4, -5, -6 and ALS

  2025cites this paper
• A double-antibody sandwich ELISA for sensitive and specific detection of insulin-like growth factor 1 in goat milk

  2025cites this paper
• Challenges of insulin-like growth factor-1 testing

  2024cites this paper
• Detection rate of IGF-1 variants and their implication to protein binding: study of over 240,000 patients

  2023cites this paper
• Adiponectin, IGFBP-1 and -2 are independent predictors in forecasting prediabetes and type 2 diabetes

  2023cites this paper
• Insulin-like growth factor role in determining the anti-cancer effect of metformin: RCT in prostate cancer patients

  2022cites this paper
• Effects of Growth Hormone Treatment on Sleep-Related Parameters in Adults With Prader-Willi Syndrome

  2021cites this paper
• Metabolic improvement after gastric bypass correlates with changes in IGF-regulatory proteins stanniocalcin-2 and IGFBP-4.

  2021cites this paper
• Development of a novel assay for IGFBP-2 complexed with IGF-I and-II in human serum.

  2020cites this paper
• The IGF system in patients with inflammatory bowel disease treated with prednisolone or infliximab: potential role of the stanniocalcin-2 / PAPP-A / IGFBP-4 axis

  2019cites this paper
• Effects of IGF-1 on the cardiovascular system.

  2019cites this paper
• PAPP-A activity is increased in cerebrospinal fluid from patients with diabetic polyneuropathy and correlates with peripheral nerve impairment.

  2019cites this paper
• The insulin-like growth factor family and breast cancer prognosis: A prospective cohort study among postmenopausal women in Denmark.

  2019cites this paper
• The Effect of Growth Hormone on IGF-1R Activation in Overweight/Obese Women

  2019cites this paper
• The effect of growth hormone on bioactive IGF in overweight/obese women.

  2018cites this paper
• Mammary metabolism and colostrogenesis in sows during late gestation and the colostral period.

  2018cites this paper
• First-in-man study with a novel PEGylated recombinant human insulin-like growth factor-I.

  2017cites this paper
• Effects of Renal Denervation on Insulin Sensitivity and Inflammatory Markers in Nondiabetic Patients with Treatment-Resistant Hypertension

  2017cites this paper
• The timing of administration of exogenous glucocorticoid affects 24hour growth hormone secretion in children.

  2017cites this paper
• Consecutive measurements show association of IGF-1 with preterm delivery in type 1 diabetic pregnancy

  2017cites this paper
• Biochemical assessment of disease control in acromegaly: reappraisal of the glucose suppression test in somatostatin analogue (SA) treated patients

  2017cites this paper
• Alcoholic Hepatitis Markedly Decreases the Capacity for Urea Synthesis

  2016cites this paper
• A characterisation of low-grade inflammation and metabolic complications in HIV-infected patients.

  2016cites this paper
• Milk yield and estrous behavior during eight consecutive estruses in Holstein cows fed standardized or high energy diets and grouped according to live weight changes in early lactation.

  2016cites this paper
• Effects of live weight adjusted feeding strategy on plasma indicators of energy balance in Holstein cows managed for extended lactation.

  2016cites this paper
• Colostrum and milk production in multiparous sows fed supplementary arginine during gestation and lactation

  2016cites this paper
• IGF-1 is associated with fetal growth and preterm delivery in type 1 diabetic pregnancy

  2016cites this paper
• womenand in response to exercise in postmenopausal Effects of transdermal estrogen on collagen turnover at

  2015cites this paper
• IGFBP-4 Fragments as Markers of Cardiovascular Mortality in Type 1 Diabetes Patients With and Without Nephropathy.

  2015cites this paper
• Clinical assays for quantitation of insulin-like-growth-factor-1 (IGF1).

  2015cites this paper
• Differential effects of low birthweight and intrauterine growth restriction on umbilical cord blood insulin‐like growth factor concentrations

  2015cites this paper
• Tissue IGF-I Measured by Microdialysis Reflects Body Glucose Utilization After rhIGF-I Injection in Type 1 Diabetes.

  2015cites this paper
• erythropoietin treatment in humans: a randomized placebo controlled trial Whole body metabolic effects of prolonged endurance training in combination with

  2015cites this paper
• between bouts of sprint exercise with different recovery periods Human growth hormone responses to repeated bouts

  2015cites this paper
• Circulating levels of pegvisomant and endogenous growth hormone during prolonged pegvisomant therapy in patients with acromegaly

  2014cites this paper
• IGFALS gene dosage effects on serum IGF-I and glucose metabolism, body composition, bone growth in length and width, and the pharmacokinetics of recombinant human IGF-I administration.

  2014cites this paper
• Effects of raloxifene and estrogen on bioactive IGF1 in GH-deficient women.

  2014cites this paper
• Short-term, low-dose GH therapy improves insulin sensitivity without modifying cortisol metabolism and ectopic fat accumulation in adults with GH deficiency.

  2014cites this paper
• Glucose homeostasis in adults with Prader-Willi syndrome during treatment with growth hormone: results from a 12-month prospective study.

  2014cites this paper
• Intraperitoneal insulin delivery to patients with type 1 diabetes results in higher serum IGF‐I bioactivity than continuous subcutaneous insulin infusion

  2014cites this paper
• athletesand biomechanical properties in female on patellar tendon morphology, biochemical Impact of oral contraceptive use and menstrual phases

  2014cites this paper
• Abomasal protein infusion in postpartum transition dairy cows: effect on performance and mammary metabolism.

  2014cites this paper
• IGF-I and IGFBP2 in peripheral artery disease: results of a prospective study

  2014cites this paper
• Prednisolone but Not Infliximab Aggravates the Upregulated Hepatic Nitrogen Elimination in Patients with Active Inflammatory Bowel Disease

  2014cites this paper
• Changes in calcitropic hormones, bone markers and insulin-like growth factor I (IGF-I) during pregnancy and postpartum: a controlled cohort study

  2013cites this paper
• No association between the intake of marine n-3 PUFA during the second trimester of pregnancy and factors associated with cardiometabolic risk in the 20-year-old offspring.

  2013cites this paper
• Two years of growth hormone treatment in adults with Prader-Willi syndrome do not improve the low BMD.

  2013cites this paper
• The macrophage low-grade inflammation marker sCD163 is modulated by exogenous sex steroids

  2013cites this paper
• Impact of oral contraceptive use and menstrual phases on patellar tendon morphology, biochemical composition, and biomechanical properties in female athletes.

  2013cites this paper
• Effect of hyperinsulinemia during hemodialysis on the insulin-like growth factor system and inflammatory biomarkers: a randomized open-label crossover study

  2013cites this paper
• Ghrelin- and GH-induced insulin resistance: no association with retinol-binding protein-4

  2013cites this paper
• Maternal milk consumption, birth size and adult height of offspring: a prospective cohort study with 20 years of follow-up

  2013cites this paper
• Determination of IGFs and their binding proteins.

  2013cites this paper
• Growth hormone treatment for two years is safe and effective in adults with Prader-Willi syndrome.

  2012cites this paper
• Local administration of growth hormone stimulates tendon collagen synthesis in elderly men.

  2012cites this paper
• Measurement of free GH and bioactive IGF-I in non-diabetic haemodialysis patients treated with GH for 7 days.

  2012cites this paper
• Prednisolone reduces the ability of serum to activate the IGF1 receptor in vitro without affecting circulating total or free IGF1.

  2012cites this paper
• Growth hormone treatment in adults with Prader-Willi syndrome: the Scandinavian study

  2012cites this paper
• Positive associations between serum levels of IGF-I and subcutaneous fat depots in young men. The Odense Androgen Study.

  2012cites this paper
• Fat content in liver and skeletal muscle changes in a reciprocal manner in patients with acromegaly during combination therapy with a somatostatin analog and a GH receptor antagonist: a randomized clinical trial.

  2012cites this paper
• The production and regulation of IGF and IGFBPs in human adipose tissue cultures.

  2012cites this paper
• Erythropoietin administration acutely stimulates resting energy expenditure in healthy young men.

  2012cites this paper
• Effects of transdermal estrogen on collagen turnover at rest and in response to exercise in postmenopausal women.

  2012cites this paper
• Local administration of insulin‐like growth factor‐I (IGF‐I) stimulates tendon collagen synthesis in humans

  2012cites this paper
• Characterisation of adiponectin multimers and the IGF axis in humans with a heterozygote mutation in the tyrosine kinase domain of the insulin receptor gene.

  2012cites this paper
• Bone mineral density in Klinefelter syndrome is reduced and primarily determined by muscle strength and resorptive markers, but not directly by testosterone

  2011cites this paper
• Normalisation of insulin‐like growth factor‐I does not improve insulin action in cirrhosis

  2011cites this paper
• Delayed β-cell response and glucose intolerance in young women with Turner syndrome

  2011cites this paper
• Counter‐regulatory hormone responses to spontaneous hypoglycaemia during treatment with insulin Aspart or human soluble insulin: a double‐blinded randomized cross‐over study

  2011cites this paper
• Insulin-like growth factor I - a novel biomarker of abdominal aortic aneurysms.

  2011cites this paper
• Cotreatment with pegvisomant and a somatostatin analog (SA) in SA-responsive acromegalic patients.

  2011cites this paper
• Identification of new biomarkers of low-dose GH replacement therapy in GH-deficient patients.

  2011cites this paper
• Exercise and NSAIDs: effect on muscle protein synthesis in patients with knee osteoarthritis.

  2011cites this paper
• Intake of fish oil during pregnancy and adiposity in 19-y-old offspring: follow-up on a randomized controlled trial.

  2011cites this paper
• Growth hormone treatment, final height, insulin-like growth factors, ghrelin, and adiponectin in four siblings with Seckel syndrome

  2011cites this paper
• Effects of insulin‐like growth factor‐I administration on in vivo regulation of urea synthesis in normal subjects and patients with cirrhosis

  2011cites this paper
• Long-term DHEA substitution in female adrenocortical failure, body composition, muscle function, and bone metabolism: a randomized trial.

  2011cites this paper
• Insulin dose–response studies in severely insulin‐resistant type 2 diabetes—evidence for effectiveness of very high insulin doses

  2011cites this paper
• Activated Protein Synthesis and Suppressed Protein Breakdown Signaling in Skeletal Muscle of Critically Ill Patients

  2011cites this paper
• Long‐term high‐physiological‐dose growth hormone reduces intra‐abdominal fat in HIV‐infected patients with a neutral effect on glucose metabolism

  2010cites this paper
• Adiponectin and Peak Bone Mass in Men: A Cross-Sectional, Population-Based Study

  2010cites this paper
• One year of growth hormone treatment in adults with Prader-Willi syndrome improves body composition: results from a randomized, placebo-controlled study.

  2010cites this paper
• Moderate energy restriction-induced weight loss affects circulating IGF levels independent of dietary composition.

  2010cites this paper
• The current status of IGF-I assays--a 2009 update.

  2010cites this paper
• Interferon-β treatment associated with a biochemical profile suggestive of acromegaly. A case report of a patient treated for multiple sclerosis

  2010cites this paper
• Circulating levels of insulin-like growth factor-II/mannose-6-phosphate receptor in obesity and type 2 diabetes.

  2010cites this paper
• Sustained low‐dose growth hormone therapy optimizes bioactive insulin‐like growth factor‐I level and may enhance CD4 T‐cell number in HIV infection

  2010cites this paper
• Conventional and novel biomarkers of treatment outcome in patients with acromegaly: discordant results after somatostatin analog treatment compared with surgery.

  2010cites this paper
• Increase in Serum Total IGF-I and Maintenance of Free IGF-I Following Intentional Weight Loss in Pre-menopausal Women at Increased Risk of Breast Cancer

  2010cites this paper
• Circulating bioactive and immunoreactive IGF-I remain stable in women, despite physical fitness improvements after 8 weeks of resistance, aerobic, and combined exercise training.

  2010cites this paper
• Body Composition : Results from a Randomized , Placebo-Controlled One Year of Growth Hormone Treatment in Adults with Prader-Willi Syndrome

  2010cites this paper
• Brief, high intensity exercise alters serum ghrelin and growth hormone concentrations but not IGF-I, IGF-II or IGF-I bioactivity.

  2010cites this paper
• Body composition, endocrine and metabolic profiles in adults with Prader-Willi syndrome.

  2010cites this paper
• Marked reductions in bioactive insulin-like growth factor I (IGF-I) during hemodialysis.

  2010cites this paper
• Normal cortisol response to high-dose synacthen and insulin tolerance test in children and adults with Prader-Willi syndrome.

  2010cites this paper
• Effect of administration of oral contraceptives in vivo on collagen synthesis in tendon and muscle connective tissue in young women.

  2009cites this paper
• Effect of abomasal glucose infusion on splanchnic and whole-body glucose metabolism in periparturient dairy cows.

  2009cites this paper
• Lycopene supplementation (passata sauce) reduces apoptosis but does not affect oxidant-responsive heme oxygenase-1 in human lymphocytes.

  2009cites this paper
• HIGHLIGHTED TOPIC Regulation of Protein Metabolism in Exercise and Recovery Effect of estrogen on tendon collagen synthesis, tendon structural characteristics, and biomechanical properties in postmenopausal women

  2009cites this paper
• Lack of effect of IGF-I on the glomerular filtration rate in non-diabetic patients with advanced chronic kidney disease.

  2009cites this paper